On the recordJuly 24, 2018
We should be able to find the money to do that without taking money away from important biomedical research and drug and device approval at the FDA.
Source
congress.govEditor's note · Context
DeGette expresses concern about Cures funding being redirected away from biomedical research.
Share
More from Diana DeGette
Mar 28, 2023
the minority intends to make sure that there is no waste, fraud, or abuse in these programs
Mar 28, 2023
It is a little embarrassing for someone like me, who is trying to tell colleagues around the world that we need to have robust oversight, that the U.S. Congress is actually having an oversight hearing that is so vague that you can't…
Apr 17, 2023
How you implement and administer consistent policies, I think, has been a challenge.
Jun 23, 2026
Pro-choice and Project allied groups should continue messaging on television and digital. New allies should know that voters who have not returned their ballots need to see contrast communications in the mailboxes — followed by TV and…
Other voices in this conversation
